10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide

C209H247N21O19 — CID 158342536

IUPAC10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide
SMILESCCC(=O)CCCCCCC(=O)N1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O.CCC(=O)CCCCCCC(=O)NCCc1c(C)[nH]c2ccccc12.CCC(=O)CCCCCCN1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O.CCC(=O)CCCCCNC(=O)C1Cc2ccccc2N1Cc1ccc(C)cc1.CCC(=O)CCCCCNC(=O)C1Cc2ccccc2N1Cc1cccc2c(N(C)C)cccc12.CCC(=O)CCCCCNC(=O)c1[nH]c2ccccc2c1C.CNC(=O)CCCCCCC(=O)CC(c1c(C)[nH]c2ccccc12)c1c(C)[nH]c2ccccc12.CNC(=O)CCCCCCC(=O)CC(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12
InChIInChI=1S/C30H29N3O4.C30H37N3O2.C29H29N3O3.C29H35N3O2.C27H31N3O2.C25H32N2O2.C21H30N2O2.C18H24N2O2/c1-2-19(34)11-5-3-4-6-16-26(35)33-29(36)27(22-17-31-24-14-9-7-12-20(22)24)28(30(33)37)23-18-32-25-15-10-8-13-21(23)25;1-4-24(34)14-6-5-9-19-31-30(35)29-20-22-12-7-8-17-27(22)33(29)21-23-13-10-16-26-25(23)15-11-18-28(26)32(2)3;1-2-19(33)11-5-3-4-10-16-32-28(34)26(22-17-30-24-14-8-6-12-20(22)24)27(29(32)35)23-18-31-25-15-9-7-13-21(23)25;1-19-28(22-13-8-10-15-25(22)31-19)24(29-20(2)32-26-16-11-9-14-23(26)29)18-21(33)12-6-4-5-7-17-27(34)30-3;1-28-27(32)15-5-3-2-4-10-19(31)16-22(23-17-29-25-13-8-6-11-20(23)25)24-18-30-26-14-9-7-12-21(24)26;1-3-22(28)10-5-4-8-16-26-25(29)24-17-21-9-6-7-11-23(21)27(24)18-20-14-12-19(2)13-15-20;1-3-17(24)10-6-4-5-7-13-21(25)22-15-14-18-16(2)23-20-12-9-8-11-19(18)20;1-3-14(21)9-5-4-8-12-19-18(22)17-13(2)15-10-6-7-11-16(15)20-17/h7-10,12-15,17-18,31-32H,2-6,11,16H2,1H3;7-8,10-13,15-18,29H,4-6,9,14,19-21H2,1-3H3,(H,31,35);6-9,12-15,17-18,30-31H,2-5,10-11,16H2,1H3;8-11,13-16,24,31-32H,4-7,12,17-18H2,1-3H3,(H,30,34);6-9,11-14,17-18,22,29-30H,2-5,10,15-16H2,1H3,(H,28,32);6-7,9,11-15,24H,3-5,8,10,16-18H2,1-2H3,(H,26,29);8-9,11-12,23H,3-7,10,13-15H2,1-2H3,(H,22,25);6-7,10-11,20H,3-5,8-9,12H2,1-2H3,(H,19,22)
InChIKeyGRIIDQZBCZWOJD-UHFFFAOYSA-N
MW3357.40 g/mol
LogP42.18
Rot. Bonds82

About 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide

10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide (PubChem CID 158342536) has the molecular formula C209H247N21O19 and a molecular weight of 3357.40 g/mol. Its IUPAC name is 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide.

Molecular Properties

Compound Name10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide
PubChem CID158342536
Molecular FormulaC209H247N21O19
Molecular Weight3357.40 g/mol
Exact Mass3354.90
IUPAC Name10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide
SMILESCCC(=O)CCCCCCC(=O)N1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O.CCC(=O)CCCCCCC(=O)NCCc1c(C)[nH]c2ccccc12.CCC(=O)CCCCCCN1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O.CCC(=O)CCCCCNC(=O)C1Cc2ccccc2N1Cc1ccc(C)cc1.CCC(=O)CCCCCNC(=O)C1Cc2ccccc2N1Cc1cccc2c(N(C)C)cccc12.CCC(=O)CCCCCNC(=O)c1[nH]c2ccccc2c1C.CNC(=O)CCCCCCC(=O)CC(c1c(C)[nH]c2ccccc12)c1c(C)[nH]c2ccccc12.CNC(=O)CCCCCCC(=O)CC(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12
InChIInChI=1S/C30H29N3O4.C30H37N3O2.C29H29N3O3.C29H35N3O2.C27H31N3O2.C25H32N2O2.C21H30N2O2.C18H24N2O2/c1-2-19(34)11-5-3-4-6-16-26(35)33-29(36)27(22-17-31-24-14-9-7-12-20(22)24)28(30(33)37)23-18-32-25-15-10-8-13-21(23)25;1-4-24(34)14-6-5-9-19-31-30(35)29-20-22-12-7-8-17-27(22)33(29)21-23-13-10-16-26-25(23)15-11-18-28(26)32(2)3;1-2-19(33)11-5-3-4-10-16-32-28(34)26(22-17-30-24-14-8-6-12-20(22)24)27(29(32)35)23-18-31-25-15-9-7-13-21(23)25;1-19-28(22-13-8-10-15-25(22)31-19)24(29-20(2)32-26-16-11-9-14-23(26)29)18-21(33)12-6-4-5-7-17-27(34)30-3;1-28-27(32)15-5-3-2-4-10-19(31)16-22(23-17-29-25-13-8-6-11-20(23)25)24-18-30-26-14-9-7-12-21(24)26;1-3-22(28)10-5-4-8-16-26-25(29)24-17-21-9-6-7-11-23(21)27(24)18-20-14-12-19(2)13-15-20;1-3-17(24)10-6-4-5-7-13-21(25)22-15-14-18-16(2)23-20-12-9-8-11-19(18)20;1-3-14(21)9-5-4-8-12-19-18(22)17-13(2)15-10-6-7-11-16(15)20-17/h7-10,12-15,17-18,31-32H,2-6,11,16H2,1H3;7-8,10-13,15-18,29H,4-6,9,14,19-21H2,1-3H3,(H,31,35);6-9,12-15,17-18,30-31H,2-5,10-11,16H2,1H3;8-11,13-16,24,31-32H,4-7,12,17-18H2,1-3H3,(H,30,34);6-9,11-14,17-18,22,29-30H,2-5,10,15-16H2,1H3,(H,28,32);6-7,9,11-15,24H,3-5,8,10,16-18H2,1-2H3,(H,26,29);8-9,11-12,23H,3-7,10,13-15H2,1-2H3,(H,22,25);6-7,10-11,20H,3-5,8-9,12H2,1-2H3,(H,19,22)
InChIKeyGRIIDQZBCZWOJD-UHFFFAOYSA-N
XLogP42.18
TPSA570.61 Ų
H-Bond Donors16
H-Bond Acceptors22
Rotatable Bonds82
Heavy Atoms249
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003357.40
LogP ≤ 542.18
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

GR 94800
CID 5487475
Ruxotemitide
CID 46200994
c[CO-(CH2)3-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2
CID 44445083
9-Ethyl-3-methyl-3H-indolo[6,7-a]pyrrolo[3,4-c]carbazole-4,6(5H,11H)-dione
CID 5330736
Indolocarbazole deriv. 13b
CID 5330775
Indolocarbazole deriv. 13c
CID 5330776
Indolocarbazole deriv. 14g
CID 5330784
Indolocarbazole deriv. 14l
CID 5330787
Spantide I
CID 25079075
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P
CID 25091011
U 68415
CID 149663
Omiganan
CID 16131445

Frequently Asked Questions

What is the IUPAC name of 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide?
The IUPAC name of 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide (CID 158342536) is 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide.
What is the SMILES notation for 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide?
The canonical SMILES for 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide is CCC(=O)CCCCCCC(=O)N1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O.CCC(=O)CCCCCCC(=O)NCCc1c(C)[nH]c2ccccc12.CCC(=O)CCCCCCN1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O.CCC(=O)CCCCCNC(=O)C1Cc2ccccc2N1Cc1ccc(C)cc1.CCC(=O)CCCCCNC(=O)C1Cc2ccccc2N1Cc1cccc2c(N(C)C)cccc12.CCC(=O)CCCCCNC(=O)c1[nH]c2ccccc2c1C.CNC(=O)CCCCCCC(=O)CC(c1c(C)[nH]c2ccccc12)c1c(C)[nH]c2ccccc12.CNC(=O)CCCCCCC(=O)CC(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12.
What is the InChIKey of 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide?
The InChIKey is GRIIDQZBCZWOJD-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H29N3O4.C30H37N3O2.C29H29N3O3.C29H35N3O2.C27H31N3O2.C25H32N2O2.C21H30N2O2.C18H24N2O2/c1-2-19(34)11-5-3-4-6-16-26(35)33-29(36)27(22-17-31-24-14-9-7-12-20(22)24)28(30(33)37)23-18-32-25-15-10-8-13-21(23)25;1-4-24(34)14-6-5-9-19-31-30(35)29-20-22-12-7-8-17-27(22)33(29)21-23-13-10-16-26-25(23)15-11-18-28(26)32(2)3;1-2-19(33)11-5-3-4-10-16-32-28(34)26(22-17-30-24-14-8-6-12-20(22)24)27(29(32)35)23-18-31-25-15-9-7-13-21(23)25;1-19-28(22-13-8-10-15-25(22)31-19)24(29-20(2)32-26-16-11-9-14-23(26)29)18-21(33)12-6-4-5-7-17-27(34)30-3;1-28-27(32)15-5-3-2-4-10-19(31)16-22(23-17-29-25-13-8-6-11-20(23)25)24-18-30-26-14-9-7-12-21(24)26;1-3-22(28)10-5-4-8-16-26-25(29)24-17-21-9-6-7-11-23(21)27(24)18-20-14-12-19(2)13-15-20;1-3-17(24)10-6-4-5-7-13-21(25)22-15-14-18-16(2)23-20-12-9-8-11-19(18)20;1-3-14(21)9-5-4-8-12-19-18(22)17-13(2)15-10-6-7-11-16(15)20-17/h7-10,12-15,17-18,31-32H,2-6,11,16H2,1H3;7-8,10-13,15-18,29H,4-6,9,14,19-21H2,1-3H3,(H,31,35);6-9,12-15,17-18,30-31H,2-5,10-11,16H2,1H3;8-11,13-16,24,31-32H,4-7,12,17-18H2,1-3H3,(H,30,34);6-9,11-14,17-18,22,29-30H,2-5,10,15-16H2,1H3,(H,28,32);6-7,9,11-15,24H,3-5,8,10,16-18H2,1-2H3,(H,26,29);8-9,11-12,23H,3-7,10,13-15H2,1-2H3,(H,22,25);6-7,10-11,20H,3-5,8-9,12H2,1-2H3,(H,19,22).
What are the key properties of 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide?
10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide has a molecular weight of 3357.40 g/mol, XLogP of 42.18, 82 rotatable bonds, 16 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 10,10-bis(1H-indol-3-yl)-N-methyl-8-oxodecanamide;3,4-bis(1H-indol-3-yl)-1-(8-oxodecanoyl)pyrrole-2,5-dione;3,4-bis(1H-indol-3-yl)-1-(7-oxononyl)pyrrole-2,5-dione;1-[[5-(dimethylamino)naphthalen-1-yl]methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide;N-methyl-10,10-bis(2-methyl-1H-indol-3-yl)-8-oxodecanamide;N-[2-(2-methyl-1H-indol-3-yl)ethyl]-8-oxodecanamide;3-methyl-N-(6-oxooctyl)-1H-indole-2-carboxamide;1-[(4-methylphenyl)methyl]-N-(6-oxooctyl)-2,3-dihydroindole-2-carboxamide is sourced from PubChem (CID 158342536), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).